MediNatura™ Becomes Exclusive U.S. Importer of Traumeel® and Zeel® Rx Pain Relief Medications

Press Release

Provides Physicians Access to Additional Treatment Options for Patients

traumeel-zeel-smPHILADELPHIA, April 3, 2015 /PRNewswire/ — MediNatura™ Incorporated, a Delaware Corporation headquartered in greater Philadelphia, announced today that the company has become the exclusive importer for the following injection solutions: Traumeel®, Zeel®, LymphomyosotX®, Spascupreel®, Neuralgo-Rheum® and Engystol®.

MediNatura™ is particularly excited to offer Traumeel® and Zeel®, given the recent clinical study results presented at the 2014 American College of Rheumatology (ACR) Annual Meeting. The study results demonstrated that co-administered Traumeel® (Tr14) and Zeel® (Ze14) intra-articular (IA) injections are safe and effective treatments for moderate to severe pain associated with knee osteoarthritis (OA) versus IA placebo. Specifically, these results showed statistically and clinically relevant pain relief for knee OA. The results were presented at ACR by Carlos Lozada M.D., who together with Roland Moskowitz M.D., helped design the trial.

Traumeel_Rx Injection_MediNaturaZeel_Rx InjectionThe abstract is available here: http://acrabstracts.org/abstracts/a-multi-center-double-blind-randomized-controlled-trial-db-rct-to-evaluate-the-effectiveness-and-safety-of-co-administered-traumeel-tr14-and-zeel-ze14-intra%e2%80%91articular-ia/.

“This study provides clinical evidence to support knee OA treatment with Traumeel® and Zeel®, providing an additional treatment option especially important for those patients who cannot tolerate non-steroidal anti-inflammatory drugs (NSAIDs), are not candidates for corticosteroid treatment or do not respond to other therapies,” noted study co-investigator Roland Moskowitz M.D., Clinical Professor of Medicine, University Hospitals, Case Medical Center.

For more information about MediNatura™ products and where to purchase them, please call 1-844-633-4628, or visit www.MediNatura.com.

About MediNatura™ Inc.

MediNatura™ Inc., is owned and led by the former executives of Heel Inc. It is headquartered in greater Philadelphia and operates Heel’s historical factory and product development facility in Albuquerque, New Mexico. MediNatura™ provides serious medicines with exceptionally safe side effect profiles. It does this by using active ingredients predominantly from natural sources.

These statements have not been reviewed by the Food and Drug Administration. They are supported by traditional homeopathic principles.
cialis next day delivery usa
Buy Aciphex online

Advertisement

Current Issue

Table of Contents

Advertisement

Trending Articles

TMW® Longevity: Creating a new generation of nutraceuticals

TMW® Longevity: Creating a new generation of nutraceuticals

GetHealthy is excited to introduce TMW® Longevity to the GetHealthy platform. TMW® (tomorrow) is leading the new generation of nutraceuticals that promise premium, scientifically curated ingredients and doses with maximum bioavailability. TMW’s first product,...

NDNR Welcomes Dr. Kareem Kandil, MD, ND as New Medical Director

NDNR Welcomes Dr. Kareem Kandil, MD, ND as New Medical Director

Scottsdale, Arizona – May 13, 2025 – Naturopathic Doctor News & Review (NDNR) proudly welcomes Dr. Kareem Kandil, MD, ND, as its incoming Medical Director. Dr. Kandil brings an exceptional combination of expertise spanning clinical practice, academic instruction,...

New FDA Tool Provides Public with Clear Data on Food Contaminants

The U.S. Food and Drug Administration (FDA) has launched the Chemical Contaminants Transparency Tool (CCT Tool), a new online database designed to inform the public about potential chemical risks in food. This searchable platform consolidates established contaminant...

Custom Publishing

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Quantum Fields and Frequency Medicine

RAZI BERRY Quantum Fields and Frequency Medicine A Conversation with Philipp Samor von Holtzendorff Fehling on Remote Quantum Technology and Human Performance Interest in frequency medicine and subtle energy technologies continues to grow...

Featured News

Allergy Research News Release

Allergy Research News Release

RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...